Updated Date:
06 Jan 2026
Product Detail:
TOPOTECAN ACCORD topotecan (as hydrochloride) 4 mg/4 mL concentrated injection vial
Shortage Status:
Current
AUST R:
310761
Availability:
Limited Availability
Active Ingredient:
topotecan hydrochloride
Reason:
Unexpected increase in consumer demand
Dosage Form:
Injection,concentrated
Supply Impact Dates
From 26 Aug 2025
To 28 Feb 2026
Management Action:
The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
